NCT05950035

Brief Summary

The goal of this two-arm pilot randomized controlled trial is to test a behavioral intervention that integrates three evidence-based cognitive behavioral interventions (written exposure therapy; WET, cognitive behavioral therapy for insomnia; CBT-I, and cognitive behavioral therapy for nightmares; CBT-N) among firefighters. The main questions it aims to answer are:

  • Is the behavioral intervention feasible, acceptable, and effective in reducing symptoms of posttraumatic stress, insomnia, and nightmares?
  • What is the efficacy of efficient treatment vs. delayed treatment (2-4 week waitlist) in reducing symptoms of posttraumatic stress, insomnia, and nightmares? We will beta test the intervention in 1-2 groups of 3-5 firefighters. Then we will randomize 50 participants to immediate or delayed (2-4 week waitlist) treatment. Consented participants will:
  • Complete self-report and interview measures assessing posttraumatic stress disorder, insomnia (PTSD), and nightmares
  • Attend an individual treatment orientation session
  • Attend a 4-day (\~3 hours per day over 4 consecutive days) group treatment that integrates WET, CBT-I, and CBT-N
  • Attend an individual booster session held approximately one week later
  • Complete self-report measures before, during, and after treatment, and at a 3-month follow up assessment and a clinical interview before and after treatment to assess program efficacy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 18, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

June 5, 2023

Last Update Submit

May 27, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Clinician Administered PTSD Scale (CAPS-5)

    The CAPS-5 is a structured clinical interview that assesses the presence and severity of PTSD symptoms.

    Change from baseline to post treatment (~4 weeks post baseline)

  • Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)

    The SCISD-R is a semi-structured interview designed to obtain a sleep history and screen for certain sleep disorders and diagnose others, including insomnia, hypersomnia, circadian rhythm sleep-wake disorders, sleep-disordered breathing, and parasomnias.

    Change from baseline to post treatment (~4 weeks post baseline)

  • Insomnia Severity Index (ISI)

    The ISI assesses perceived severity of insomnia.

    Change from baseline through 3 months post treatment

  • Nightmare Disorders Index

    The NDI is a self-report assessment of nightmare disorder.

    Change from baseline through 3 months post treatment

  • Posttraumatic Stress Disorder Checklist (PCL-5)

    Self-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5.

    Change from baseline through 3 months post treatment

Secondary Outcomes (6)

  • Trauma-Related Nightmare Survey (TRNS)

    Change from baseline through 3 months post treatment

  • Self-Assessment of Sleep (SASS)

    Change from baseline through 3 months post treatment

  • Sleep Diary and Nightmare Log

    Change from baseline through post treatment (~4 weeks post baseline)

  • Patient Health Questionnaire-9 (PHQ-9)

    Change from baseline through 3 months post treatment

  • Depressive Symptoms Index-Suicidality Subscale (DSI-SS)

    Change from baseline through 3 months post treatment

  • +1 more secondary outcomes

Study Arms (2)

Immediate Intervention

EXPERIMENTAL

Will begin treatment within 2 weeks of randomization.

Behavioral: Written Exposure Therapy (WET)Behavioral: Cognitive Behavioral Therapy for Insomnia (CBTi)Behavioral: Cognitive Behavioral Therapy for Nightmares (CBTn)

Delayed Intervention

ACTIVE COMPARATOR

Will be scheduled to begin treatment within 4-6 weeks of randomization.

Behavioral: Waitlist

Interventions

WET is a trauma-focused intervention in which individuals write about their worst traumatic experience following scripted instruction from the therapist.

Immediate Intervention

CBTi focuses on stimulus control, eliminating maladaptive coping habits, reducing arousal, and challenging maladaptive thoughts about sleep in an effort to reduce time to fall asleep and time awake during the night.

Immediate Intervention

CBTn involves writing about a distressing or frequent nightmare, rewriting the narrative of the nightmare to target trauma-related themes, and reading the rescripted nightmare narrative.

Immediate Intervention
WaitlistBEHAVIORAL

Waitlist for delayed intervention.

Delayed Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • Firefighter
  • Able to speak and read English
  • Clinically significant posttraumatic stress symptoms: CAPS-5 total score ≥ 25; ≥ 1 intrusion symptom; ≥ 1 avoidance symptom
  • Clinically significant symptoms of insomnia: SCISD insomnia criteria are met; ISI ≥ 15
  • Clinically significant symptoms of nightmare disorder: SCISD nightmare disorder criteria are met, nightmares ≥ 1 monthly.

You may not qualify if:

  • Current suicide or homicide risk meriting crisis intervention
  • Inability to speak and read English
  • Inability to comprehend the baseline screening questionnaires
  • Unwilling to remain abstinent from alcohol during treatment
  • Serious mental health diagnosis such as bipolar disorder or psychosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NDRI_USA

Kansas City, Missouri, 66224, United States

Location

Related Publications (1)

  • McLean CP, Janke S, Pruiksma KE, Taylor DJ, Sloan DM, Dietch JR, Fredman SJ, Sutherland C, Hollerbach B, Thompson SM, Tse D, Nagy S, Malek N, Haddock CK. A pilot feasibility randomized clinical trial of a culturally adapted accelerated group treatment for posttraumatic stress, insomnia, and nightmares in firefighters. Psychol Trauma. 2026 Jan 19. doi: 10.1037/tra0002090. Online ahead of print.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSleep Initiation and Maintenance Disorders

Interventions

Cognitive Behavioral TherapyWaiting Lists

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesAppointments and SchedulesOrganization and AdministrationHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Psychologist

Study Record Dates

First Submitted

June 5, 2023

First Posted

July 18, 2023

Study Start

December 1, 2023

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

May 31, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations